%0 Journal Article
%T 新型TK抑制剂达克替尼在肺腺癌细胞增殖和凋亡的影响<br>Effect of a Novel TK Inhibitor Dacomitinib on Proliferation and Apoptosis of Lung Adenocarcinoma Cells
%A 郭李玲
%A 毛俊
%J Hans Journal of Medicinal Chemistry
%P 112-118
%@ 2331-8295
%D 2021
%I Hans Publishing
%R 10.12677/HJMCe.2021.93014
%X 目的：探究新型TK抑制剂达克替尼对人肺腺癌A549细胞增殖与侵袭作用及机制。方法：人肺腺癌A549细胞为研究对象，根据预实验结果，将人肺腺癌细胞系A549分成3组，即空白对照组，低剂量组和高剂量组。RT-PCR检测EFGR和凋亡蛋白Caspase-3和Caspase-9的表达，流式细胞仪检测细胞的分裂周期和细胞凋亡率，CCK-8检测细胞的增殖。结果：空白对照组，低剂量组和高剂量组的EFGR，Caspase-3和Caspase-9 mRNA相对表达量相对量比较具有统计学差异(P &lt; 0.05)；空白对照组的EFGR mRNA相对表达量相对量要明显高于低剂量组和高剂量组(P &lt; 0.05)，空白对照组的Caspase-3和Caspase-9 mRNA相对表达量要明显低于低剂量组和高剂量组(P &lt; 0.05)，低剂量组和高剂量组的EFGR，Caspase-3和Caspase-9 mRNA相对表达量相对量比较无统计学差异(P&gt;0.05)。低剂量组和高剂量组的G0/G1期比例明显高于空白对照组(P &lt; 0.05)；S期和G2期比例明显低于空白对照组(P &lt; 0.05)。低剂量组和高剂量组的总凋亡率明显高于空白对照组(P &lt; 0.05)；高剂量组晚期凋亡率明显高于低剂量组(P &lt; 0.05)。药物处理2天后，空白对照组的细胞增值率要明显高于低剂量组和高剂量组(P &lt; 0.05)；药物处理3天后，空白对照组的细胞增值率要明显高于低剂量组和高剂量组(P &lt; 0.05)。结论：低剂量达克替尼可以抑制肺腺癌细胞的增殖，促进肺腺癌细胞的凋亡，并且可以抑制EFGR的表达，可以作为耐药性肺腺癌的治疗方案。<br />
Objective: The objective is to investigate the proliferation and invasion of human lung adenocar-cinoma A549 cells induced by a novel TK inhibitor, dacomitinib, and its mechanism. Methods: Human lung adenocarcinoma cell line A549 was divided into three groups according to the pre-liminary results, namely the blank control group, the low-dose group and the high-dose group. The expression of EFGR and Caspase-3 and Caspase-9 was detected by RT-PCR. The cycle of cell division and apoptotic rate of the cell were detected by flow cytometry. The cell proliferation was detected by CCK-8. Results: The relative expressions of EFGR, caspase-3 and caspase-9 mRNA in blank control group, low-dose group and high-dose group were statistically different (P &lt; 0.05). The relative expression of EFGR mRNA in the blank control group was significantly higher than that in the low-dose group and the high-dose group (P &lt; 0.05). The relative expression of Caspase-3 and caspase-9 mRNA in the blank control group was significantly lower than that in the low-dose group and high-dose group (P &lt; 0.05). There was no significant difference in the relative expression of EFGR, caspase-3 and caspase-9 mRNA between the low-dose group and the high-dose group (P &gt; 0.05). The proportions of G0/G1 phase in low-dose group and high-dose group were significantly higher than those in blank control group (P &lt; 0.05), while the proportions of S phase and G2 phase were significantly lower than those in blank control group (P &lt; 0.05). The total apoptotic rate of the low-dose group and the high-dose group significantly higher than that of the blank control group (P &lt; 0.05), and the late apoptotic rate of the high-dose group was significantly higher than that of the low-dose group (P &lt; 0.05). After 2 days of drug treatment, the cell increment rate of blank
%K 达克替尼，肺腺癌，增殖，凋亡<br>Dacomitinib
%K Lung Adenocarcinoma
%K Proliferation
%K Apoptosis
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=44565